Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, VolitionRx Limited reported revenue of $2M, up 40.0% year over year. Operating margin was -1258.5% and net margin -1352.2%, on a free-cash-flow margin of -1144.7% with capital expenditure at 5.2% of revenue. Every figure is computed directly from VNRX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2M | -1258.5% | -1352.2% |
| FY2024 | $1M | -2190.9% | -2186.3% |
| FY2023 | $1M | -4641.8% | -4601.7% |
| FY2022 | $0M | -10372.4% | -9986.7% |
| FY2021 | $0M | -31469.0% | -29977.0% |
How does VNRX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.